Literature DB >> 29932369

Autologous cervical fascia duraplasty in 123 children and adults with Chiari malformation type I: surgical technique and complications.

Brian J Dlouhy1,2, Arnold H Menezes1.   

Abstract

OBJECT Techniques for combined extradural and intradural decompression with expansile duraplasty for Chiari malformation type I (CM-I) have been well described, with various allogenic and autologous materials used for duraplasty. However, the approach and surgical technique used for duraplasty in our treatment of CM-I and developed by the senior author in the 1990s has not been described. METHODS A prospective database was initiated in March 2003 to denote the use of cervical fascia for duraplasty and incorporate an ongoing detailed record of complications during the surgical treatment of children and adults with CM-I with and without syringomyelia. A total of 389 surgeries for CM-I were performed on 379 patients from March 2003 to June 2016. A total of 123 posterior procedures were performed on 123 patients in which both a posterior fossa extradural and intradural decompression with duraplasty (extra-intradural) was performed. In this paper the authors describe the surgical technique for harvesting and using cervical fascia for duraplasty in the surgical treatment of CM-I and analyze and discuss complications from a prospective database spanning 2003-2016. RESULTS The authors found that cervical fascia can be harvested in patients of all ages (2-61 years old) without difficulty, and it provides a good substitute for dura in creating an expansile duraplasty in patients with CM-I. Cervical fascia is an elastic-like material with a consistency that allows for a strong watertight closure. Harvesting the cervical fascia graft does not require any further extension of the incision superiorly or inferiorly to obtain the graft. Complications were uncommon in this study of 123 children and adults. The risk of any type of complication (aseptic meningitis, CSF leak, pseudomeningocele, infection, development of hydrocephalus, and need for ventriculoperitoneal shunt) for the 78 patients in the pediatric age group was 0%. The risk of complication in the adult group was 6.7% (1 patient with aseptic meningitis and 2 patients with CSF leak). CONCLUSIONS Autologous cervical fascia is easy to obtain in patients of all ages and provides an effective material for duraplasty in the treatment of CM-I. Complications from the combination of both an extradural and intradural decompression with autologous cervical fascia duraplasty are uncommon.

Entities:  

Keywords:  CJV = craniovertebral junction; CM-I = Chiari malformation type I; Chiari I malformation; allograft; duraplasty; extradural; intradural; pericranium; surgical technique; syringomyelia; tonsillar ectopia; tonsillar herniation

Mesh:

Year:  2018        PMID: 29932369     DOI: 10.3171/2018.3.PEDS17550

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  4 in total

1.  Outcomes and complications for individual neurosurgeons for the treatment of Chiari I malformation at a children's hospital.

Authors:  Tasha-Kay Walker-Palmer; D Douglas Cochrane; Ashutosh Singhal; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2019-05-24       Impact factor: 1.475

2.  Cognitive and Psychological Functioning in Chiari Malformation Type I Before and After Surgical Decompression - A Prospective Cohort Study.

Authors:  Scott C Seaman; Carolina Deifelt Streese; Kenneth Manzel; Janina Kamm; Arnold H Menezes; Daniel Tranel; Brian J Dlouhy
Journal:  Neurosurgery       Date:  2021-11-18       Impact factor: 5.315

3.  Sequential Enlargement of Posterior Fossa After Duraplasty for Chiari Malformation Type 1.

Authors:  Yasuhiro Takeshima; Ryosuke Matsuda; Fumihiko Nishimura; Ichiro Nakagawa; Yasushi Motoyama; Young-Soo Park; Hiroyuki Nakase
Journal:  World Neurosurg X       Date:  2019-01-07

4.  Biomechanical characterization of human temporal muscle fascia in uniaxial tensile tests for graft purposes in duraplasty.

Authors:  Johann Zwirner; Benjamin Ondruschka; Mario Scholze; Gundula Schulze-Tanzil; Niels Hammer
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.